American Vanguard (NYSE:AVD – Get Free Report)‘s stock had its “sell (e+)” rating reiterated by research analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.
Separately, Wall Street Zen upgraded American Vanguard from a “hold” rating to a “buy” rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $12.00.
Read Our Latest Research Report on AVD
American Vanguard Stock Performance
American Vanguard (NYSE:AVD – Get Free Report) last announced its earnings results on Thursday, July 31st. The basic materials company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.08. American Vanguard had a negative return on equity of 26.21% and a negative net margin of 23.72%.The business had revenue of $129.31 million for the quarter, compared to the consensus estimate of $130.00 million.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. Strs Ohio acquired a new stake in shares of American Vanguard in the first quarter worth about $28,000. CWM LLC lifted its position in shares of American Vanguard by 134.7% in the 1st quarter. CWM LLC now owns 9,425 shares of the basic materials company’s stock worth $41,000 after acquiring an additional 5,410 shares during the period. Aigen Investment Management LP acquired a new position in shares of American Vanguard in the 1st quarter worth approximately $44,000. Cerity Partners LLC acquired a new position in shares of American Vanguard in the 1st quarter worth approximately $48,000. Finally, XTX Topco Ltd acquired a new position in shares of American Vanguard in the 2nd quarter worth approximately $57,000. Hedge funds and other institutional investors own 79.00% of the company’s stock.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Further Reading
- Five stocks we like better than American Vanguard
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
- Dividend Capture Strategy: What You Need to Know
- Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
- Are Penny Stocks a Good Fit for Your Portfolio?
- Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.
